Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Challenges in Influenza diagnostics in a swine herd - a case report].
Unterweger C, Debeerst S, Klingler E, Auer A, Redlberger-Fritz M, Stadler J, Pesch S, Lillie-Jaschniski K, Ladinig A. Unterweger C, et al. Among authors: redlberger fritz m. Tierarztl Prax Ausg G Grosstiere Nutztiere. 2021 Dec;49(6):425-431. doi: 10.1055/a-1580-6938. Epub 2021 Dec 3. Tierarztl Prax Ausg G Grosstiere Nutztiere. 2021. PMID: 34861735 German.
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic.
Melidou A, Pereyaslov D, Hungnes O, Prosenc K, Alm E, Adlhoch C, Fielding J, Sneiderman M, Martinuka O, Celentano LP, Pebody R; WHO European Region influenza surveillance network; WHO European Region Influenza Surveillance Network author list. Melidou A, et al. Euro Surveill. 2020 Nov;25(46):2001822. doi: 10.2807/1560-7917.ES.2020.25.46.2001822. Euro Surveill. 2020. PMID: 33213683 Free PMC article.
Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019.
Segaloff H, Melidou A, Adlhoch C, Pereyaslov D, Robesyn E, Penttinen P, Olsen SJ, Region WE; European Influenza Surveillance Network; WHO European Region and European Influenza Surveillance Network. Segaloff H, et al. Euro Surveill. 2019 Feb;24(9):1900125. doi: 10.2807/1560-7917.ES.2019.24.9.1900125. Euro Surveill. 2019. PMID: 30862331 Free PMC article.
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers.
Radner H, Sieghart D, Jorda A, Fedrizzi C, Hasenöhrl T, Zdravkovic A, Redlberger-Fritz M, Puchammer-Stoeckl E, Anderle K, Bergmann F, Firbas C, Jordakieva G, Wagner B, Haslacher H, Perkmann T, Heinz LX, Bonelli M, Crevenna R, Aletaha D, Zeitlinger M. Radner H, et al. Among authors: redlberger fritz m. Clin Microbiol Infect. 2023 May;29(5):635-641. doi: 10.1016/j.cmi.2022.12.008. Epub 2022 Dec 9. Clin Microbiol Infect. 2023. PMID: 36509374 Free article. Clinical Trial.
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Adlhoch C, Delgado-Sanz C, Carnahan A, Larrauri A, Popovici O, Bossuyt N, Thomas I, Kynčl J, Slezak P, Brytting M, Guiomar R, Redlberger-Fritz M, Maistre Melillo J, Melillo T, van Gageldonk-Lafeber AB, Marbus SD, O'Donnell J, Domegan L, Gomes Dias J, Olsen SJ. Adlhoch C, et al. Among authors: redlberger fritz m. Euro Surveill. 2023 Jan;28(4):2200340. doi: 10.2807/1560-7917.ES.2023.28.4.2200340. Euro Surveill. 2023. PMID: 36700868 Free PMC article.
Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Moser T, Seiberl M, Feige J, Bieler L, Radlberger RF, O'Sullivan C, Pilz G, Harrer A, Schwenker K, Haschke-Becher E, Machegger L, Grimm J, Redlberger-Fritz M, Buchmann A, Khalil M, Kvas E, Trinka E, Wipfler P. Moser T, et al. Front Immunol. 2021 Aug 26;12:718895. doi: 10.3389/fimmu.2021.718895. eCollection 2021. Front Immunol. 2021. PMID: 34512642 Free PMC article. Clinical Trial.
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.
Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D, Kundi M, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl E, Morokutti A, Wolschek M, Ferko B, Seipelt J, Dick-Gudenus R, Muster T. Wacheck V, et al. J Infect Dis. 2010 Feb 1;201(3):354-62. doi: 10.1086/649428. J Infect Dis. 2010. PMID: 20039806 Clinical Trial.
51 results